Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Dave Baron"'
Autor:
Dave Baron
Winner, ISHS Annual Award for a Scholarly Publication, 2017 With a population of about two thousand, Pembroke Township, one of the largest rural, black communities north of the Mason-Dixon Line, sits in an isolated corner of Kankakee County, Illinois
Autor:
Imran Siddiqi, Maxwell Marino, Devendra K. Agrawal, Dave Baron, David A. Connett, Daniel Miulli
Publikováno v:
Journal of Biotechnology and Biomedicine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b96ccfd02595552721e69a345ddaf09
https://doi.org/10.26502/jbb.2642-91280075
https://doi.org/10.26502/jbb.2642-91280075
Publikováno v:
Depression and Anxiety. 33:718-727
Ketamine was discovered in the 1960s and released for public use in 1970. Originally developed as a safer alternative to phencyclidine, ketamine is primarily used in clinical settings for analgesia and sedation. In recent years, other uses have been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dcd28d29c5ea0b8030d3e9c5e1221fe6
https://doi.org/10.1002/da.22536
https://doi.org/10.1002/da.22536
Publikováno v:
The Journal of the American Osteopathic Association. 118(2)
Addiction is a public health crisis in the United States. Understanding the cause and providing effective treatment for patients—in particular, those with substance use disorders—is challenging. Research has demonstrated that addiction is not a f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7182b19e892d062164972cf58975303a
https://pubmed.ncbi.nlm.nih.gov/29379966
https://pubmed.ncbi.nlm.nih.gov/29379966
Publikováno v:
Depression and anxiety. 33(8)
Ketamine was discovered in the 1960s and released for public use in 1970. Originally developed as a safer alternative to phencyclidine, ketamine is primarily used in clinical settings for analgesia and sedation. In recent years, other uses have been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::801a0616e9433154275eb2e7363a91b2
https://pubmed.ncbi.nlm.nih.gov/27328618
https://pubmed.ncbi.nlm.nih.gov/27328618
Autor:
Matthew W. Lorence, Peter S. Pesheck, J. Tang, F.P. Resurreccion, B. Wäppling-Raaholt, T. Ohlsson, Per O. Risman, N. Cooper, S.J. Risch, A.J. Gallo, Ronald R. Lentz, Michael R. Perry, Timothy H. Bohrer, Dave Baron, M. Celuch, P. Kopyt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0aaf14e30d8b70afa7a2ba2b091c9abb
https://doi.org/10.1016/b978-1-84569-420-3.50018-4
https://doi.org/10.1016/b978-1-84569-420-3.50018-4
Publikováno v:
American journal of psychotherapy. 45(3)
Patients were recruited from the UCLA AIDS Research Center who had previously been referred to psychiatry for participation in an open-label pilot treating patients with major depression with fluoxetine. They chose to participate in group therapy for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fc7f4a4335688fdb9302c0e2e3885bc
https://pubmed.ncbi.nlm.nih.gov/1951789
https://pubmed.ncbi.nlm.nih.gov/1951789